Sabina Y. van der Zanden

Uncoupling DNA damage from chromatin damage to detoxify doxorubicin

Xiaohang Qiao, Sabina Y. van der Zanden, Dennis P. A. Wander et al. · Proceedings of the National Academy of Sciences · 2020 · 168 citations · Full text

Medicine, Oncology, Pharmacology +17

SKIP‐HOPS recruits TBC1D15 for a Rab7‐to‐Arl8b identity switch to control late endosome transport

Marlieke L.M. Jongsma, Jeroen Bakker, Birol Cabukusta et al. · The EMBO Journal · 2020 · 113 citations · Full text

Life Sciences, Cell Biology, Molecular Biology +17

Genome-Wide Identification and Characterization of Novel Factors Conferring Resistance to Topoisomerase II Poisons in Cancer

Ruud H. Wijdeven, Baoxu Pang, Sabina Y. van der Zanden et al. · Cancer Research · 2015 · 72 citations

Medicine, Oncology, Pharmacology +16

Doxorubicin and Aclarubicin: Shuffling Anthracycline Glycans for Improved Anticancer Agents

Dennis P. A. Wander, Sabina Y. van der Zanden, Gijsbert A. van der Marel et al. · Journal of Medicinal Chemistry · 2020 · 38 citations · Full text

Medicine, Medicinal Chemistry, Oncology +14

Immunoproteasome Inhibitor–Doxorubicin Conjugates Target Multiple Myeloma Cells and Release Doxorubicin upon Low-Dose Photon Irradiation

Elmer Maurits, Michel J. van de Graaff, Santina Maiorana et al. · Journal of the American Chemical Society · 2020 · 24 citations · Full text

Medicine, Oncology, Pharmacology +15